BioVaxys Technology Corp. (BVAXF)
OTCMKTS · Delayed Price · Currency is USD
0.0197
-0.0003 (-1.50%)
Sep 9, 2025, 3:41 PM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of $6.36 million as of September 10, 2025. Its market cap has decreased by -34.22% in one year.
Market Cap
6.36M
Enterprise Value
6.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 20.38M to 6.36M, a decrease of -68.77%. That is a compound annual growth rate of -21.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 6.36M | -44.43% |
| Dec 31, 2024 | 11.45M | 108.44% |
| Dec 29, 2023 | 5.49M | -46.60% |
| Dec 30, 2022 | 10.29M | -31.16% |
| Dec 31, 2021 | 14.94M | 33.01% |
| Dec 31, 2020 | 11.23M | -44.87% |
| Oct 6, 2020 | 20.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 742.62M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |